A comparison of indocyanine green fluorescence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients

Annals of Surgical Oncology

Volumn 19, Issue 13, 2012, Pages 4112-4116

  Hirano, Akira ^a   Kamimura, Mari ^a   Ogura, Kaoru ^a   Kim, Naomi ^a   Hattori, Akinori ^a   Setoguchi, Yumika ^a   Okubo, Fumie ^a   Inoue, Hiroaki ^a   Miyamoto, Reiko ^a   Kinoshita, Jun ^a   Fujibayashi, Mariko ^a   Shimizu, Tadao ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFINE BLUE; INDOCYANINE GREEN;

ADULT; AGED; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FLUORESCENCE IMAGING; HUMAN; MAJOR CLINICAL STUDY; REVIEW; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; SENTINEL NODE NAVIGATION SURGERY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COLORING AGENTS; FEMALE; FLUORESCENCE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INDOCYANINE GREEN; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOPHARMACEUTICALS; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY;

EID: 84876495761     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2478-0     Document Type: Review

References (20)

1. Krag DN, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med. 1988;339:941-6.
2. Goldhirsch A, Wood WC, Galber RD, et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007;18: 1133-44. (Pubitemid 47244357)
3. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927-33.
4. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645-53. (Pubitemid 28530914)
5. Rutgers EJ. Guidelines to assure quality in breast cancer surgery. Eur J Surg Oncol. 2005;31:568-76. (Pubitemid 40975238)
6. Sanidas EE, de Bree E, Tsiftsis DD. How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg. 2003;185:202-10. (Pubitemid 36298883)
7. Schwartz GF, Giuliano AE, Veronesi U; Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19 to 22, 2001, Philadelphia, Pennsylvania. Hum Pathol. 2002;33: 579-89. (Pubitemid 34827538)
8. Sanidas EE, Daskalakis M, Sbyrakis N, et al. Modifications of the learning curve guidelines for breast cancer sentinel node biopsy. Eur J Surg Oncol. 2005;31:357-63. (Pubitemid 40521299)
9. Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005;12:211-5.
10. Tagaya N, Yamazaki R, Nakagawa A, et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg. 2008;195:850-3. (Pubitemid 351749448)
11. McMasters KM, Wong SL, Martin RCG II, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiin-stitutional study. Ann Surg. 2001;233:676-87. (Pubitemid 32378652)
12. Kang SW, Chung SE, Shin WJ, et al. Polypoidal choroidal vas-culopathy and late geographic hyperfluorescence on indocyanine green angiography. Br J Ophthalmol. 2009;93:759-64.
13. SchneiDer PD. Preoperative assessment of liver function. Surg Clin North Am. 2004;84:355-73. (Pubitemid 38388272)
14. Vogt PR, Bauer EP, Graves K. Novadaq SPY Intraoperative imaging system-current status. Thorac Cardiovasc Surg. 2003; 51:49-51. (Pubitemid 36603948)
15. Hirsche C, Murawa D, Mohr Z, Kneif S, Hunerbein M. ICG fluorescent-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat. 2010;121:373-8.
16. Tagaya N, Tsumuraya M, Nakagawa A, et al. 2010 Indocyanine green (ICG) fluorescence imaging versus radioactive colloid for sentinel lymph node identification in patients with breast cancer. J Clin Oncol 28:674.
17. Aoyama K, Kamio T, Nishizawa M, et al. Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green. World J Surg Oncol. 2011;9:157.
18. Bass SS, Cox CE, Reintgen DS, et al. Learning curves and certification for breast cancer lymphatic mapping. Surg Oncol Clin N Am. 1999;8:497-509. (Pubitemid 29321459)
19. Dupont E, Cox C, Shivers S, et al. Learning curves and breast cancer lymphatic mapping: Institutional volume index. J Surg Res. 2001;97:92-6. (Pubitemid 34948226)
20. Hojo T, Nagao T, Kikuyama M, et al. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast. 2010;19:210-3.